Predicting non-small cell lung cancer expression of epidermal growth factor receptor and matrix metalloproteinase 9 from immunohistochemical staining of diagnostic biopsy samples
- 31 July 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (10) , 1589-1592
- https://doi.org/10.1016/j.ejca.2004.02.022
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancerAnnals of Oncology, 2004
- Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of CancerJournal of Clinical Oncology, 2003
- Prognostic impact of matrix metalloproteinase‐9 in operable non‐small cell lung cancerInternational Journal of Cancer, 2002
- Epidermal growth factor receptor family in lung cancer and premalignancySeminars in Oncology, 2002
- EGFR and cancer prognosisPublished by Elsevier ,2001
- Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based studyThorax, 2001
- Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical ResultsInvestigational New Drugs, 1999
- The plasmin cascade and matrix metalloproteinases in non-small cell lung cancerThorax, 1999
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyPublished by Elsevier ,1997
- Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase aInternational Journal of Cancer, 1995